| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.21T | 1.21T | 1.18T | 1.10T | 936.04B |
| Gross Profit | 368.37B | 358.29B | 326.50B | 253.22B | 259.70B |
| EBITDA | 169.46B | 171.11B | 156.23B | 97.31B | 119.70B |
| Net Income | 50.38B | 9.87B | 37.05B | 9.41B | 29.47B |
Balance Sheet | |||||
| Total Assets | 1.46T | 1.34T | 1.27T | 1.23T | 1.09T |
| Cash, Cash Equivalents and Short-Term Investments | 98.64B | 100.38B | 90.25B | 73.85B | 75.09B |
| Total Debt | 322.05B | 315.52B | 310.93B | 357.89B | 283.75B |
| Total Liabilities | 723.62B | 665.31B | 625.30B | 661.34B | 572.63B |
| Stockholders Equity | 716.08B | 656.13B | 624.11B | 546.20B | 501.54B |
Cash Flow | |||||
| Free Cash Flow | 91.53B | 47.53B | 106.50B | -39.45B | 15.36B |
| Operating Cash Flow | 150.43B | 104.33B | 169.80B | 27.87B | 63.09B |
| Investing Cash Flow | -186.56B | -64.66B | -62.23B | -78.70B | -53.24B |
| Financing Cash Flow | 30.88B | -35.62B | -95.57B | 41.56B | -14.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥579.12B | 10.49 | 15.27% | 2.93% | 2.81% | 2.78% | |
75 Outperform | ¥496.21B | 7.76 | 8.58% | 2.62% | 1.44% | -0.92% | |
73 Outperform | ¥142.56B | 16.04 | ― | 5.78% | -4.26% | 17.85% | |
70 Outperform | ¥554.59B | 12.60 | 4.89% | 2.59% | -0.26% | 129.15% | |
68 Neutral | ¥4.28T | 14.28 | 6.59% | 3.07% | 0.24% | -23.93% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥987.86B | 9.00 | 9.11% | 1.60% | 10.53% | -2.52% |